Ask AI
ProCE Banner Activity

CE

Expert Highlights of Practical Advances in CLL/SLL Treatment and Nursing Management

Video

In this certified on-demand webcast, expert nursing faculty address prognostic testing, current and emerging treatment options, and nursing management strategies for patients with CLL/SLL based on evidence from key clinical trials and current guideline recommendations.

Nurse Practitioners/Nurses: 0.75 Nursing contact hour

Released: June 01, 2026

Expiration: November 30, 2026

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by educational grants from BeOne Medicines USA Inc. and Lilly.

BeOne Medicines USA Inc.

Lilly

Target Audience

This activity has been designed to meet the educational needs of nurse practitioners, oncology nurses, and other healthcare professionals involved in the management of CLL/SLL.

Program Learning Goal

This activity aims to improve learner knowledge and competence in optimizing the care of patients with CLL/SLL who are receiving treatment with targeted agents.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Explain targeted agents to patients with CLL/SLL according to their rationale, mechanisms of action, efficacy, and adverse event profiles 

  • Support patients’ goals and preferences when receiving treatment for newly diagnosed or relapsed/refractory CLL/SLL, considering prognostic variables, comorbidities, duration, and toxicity profiles

  • Evaluate current and emerging efficacy and safety evidence for the use of targeted agents, including CAR T-cells, in first-line, second-line, and later-line treatment of CLL/SLL

  • Identify and manage adverse events associated with targeted agents for CLL/SLL to improve duration on treatment and clinical outcomes

  • Use enhanced communication strategies to support patient engagement in care, including strategies to recognize and address adverse events, drug interactions, and treatment adherence 

Disclosure

Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Amy Goodrich, RN, MSN, CRNP: consultant/advisor/speaker: BeiGene, Incyte, Lilly.

The planners and content peer reviewers from Decera Clinical Education do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from June 01, 2026, through November 30, 2026:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.75 contact hours.